[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
March 16, 2011

Updated Funding Information in: Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants: A Randomized Controlled Trial

JAMA. 2011;305(11):1096. doi:10.1001/jama.2011.306

Updated Funding Information: In the Original Contribution entitled “Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants: A Randomized Controlled Trial,” published in the January 9/16, 2008, issue of JAMA (2008;299[2]:173-184), the Funding/Support paragraph should have included the following: The Oxford Vaccine Group receives funding from the NIHR Oxford Partnership Comprehensive Biomedical Research Centre program (including salary support for Ms John and Dr Snape). This article has been corrected online.

×